Evidence map›Paper›PMID 28416650›Full record

ArticleThe Journal of experimental medicine2017

Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs.

Shixin Ma, Xiaoling Wan, Zihou Deng, Lei Shi, Congfang Hao, Zhenyuan Zhou, Chun Zhou, Yiyuan Fang, Jinghua Liu, Jing Yang and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. CXXC5 is a ubiquitinated protein and is degraded by the ubiquitin-proteasome pathway.Protein science : a publication of the Protein Society · 2025
    Article
  6. Article
  7. Article
  8. Signal integrator function of CXXC5 in Cancer.Cell communication and signaling : CCS · 2025
    Review
  9. Review
  10. Article
  11. DNA 5mC and RNA mInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Single-cell profiling aligns CD56Frontiers in immunology · 2024
    Article
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 2 countries.

Shixin MaCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.ORCID 0000-0002-7701-1512
Xiaoling WanCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Zihou DengCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Lei ShiCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.ORCID 0000-0002-2913-1747
Congfang HaoCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.ORCID 0000-0002-3970-4457
Zhenyuan ZhouShanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200240, China.
Chun ZhouCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Yiyuan FangCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Jinghua LiuCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.ORCID 0000-0002-5502-8102
Jing YangCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Xia ChenCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Tiantian LiCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Aiping ZangCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Shigang YinCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Bin LiCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Joel PlumasInstitute for Advanced Biosciences (IAB), Team Immunobiology and Immunotherapy in Chronic Diseases, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de la Recherche Scientifique UMR5309, Université Grenoble Alpes, Etablissement Français du Sang-Rhone-Alpes, F-38700 Grenoble, France.
Laurence ChaperotInstitute for Advanced Biosciences (IAB), Team Immunobiology and Immunotherapy in Chronic Diseases, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de la Recherche Scientifique UMR5309, Université Grenoble Alpes, Etablissement Français du Sang-Rhone-Alpes, F-38700 Grenoble, France.ORCID 0000-0002-1479-9410
Xiaoming ZhangCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Guoliang XuState Key Laboratory of Molecular Biology, CAS Excellence Center in Molecular Cell Sciences, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Lubin JiangCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Nan ShenShanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200240, China.
Sidong XiongInstitute of Biology and Medical Sciences, Soochow University, Soochow, Jiangsu 215006, China.
Xiaoming GaoInstitute of Biology and Medical Sciences, Soochow University, Soochow, Jiangsu 215006, China.
Yan ZhangCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Hui XiaoCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai; CAS Center for Excellence in Molecular Cell Sciences; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China huixiao@ips.ac.cn.ORCID 0000-0001-5304-243X
Institut Pasteur of Shanghai · CNChinese Academy of Sciences · CNSoochow University · CNCentre National de la Recherche Scientifique · FRShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TLR7/9 signals are capable of mounting massive interferon (IFN) response in plasmacytoid dendritic cells (pDCs) immediately after viral infection, yet the involvement of epigenetic regulation in this process has not been documented. Here, we report that zinc finger CXXC family epigenetic regulator CXXC5 is highly expressed in pDCs, where it plays a crucial role in TLR7/9- and virus-induced IFN response. Notably, genetic ablation of CXXC5 resulted in aberrant methylation of the CpG-containing island (CGI) within the

Indexed as

AnimalsCpG IslandsDendritic CellsDioxygenasesDNA-Binding ProteinsDNA MethylationEpigenesis, GeneticHerpes SimplexInterferonsIntracellular Signaling Peptides and ProteinsMembrane GlycoproteinsMiceMice, Inbred C57BLProto-Oncogene ProteinsToll-Like Receptor 7Toll-Like Receptor 9CXXC5 protein, mouseDioxygenasesDNA-Binding ProteinsInterferonsIntracellular Signaling Peptides and ProteinsMembrane GlycoproteinsProto-Oncogene ProteinsTet2 protein, mouseTlr7 protein, mouseTlr9 protein, mouseToll-Like Receptor 7Toll-Like Receptor 9Transcription Factors

Identifiers

PMID28416650
PMCPMC5413332
OpenAlexW2607074317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.